Cassiopea announces results of ordinary and extraordinary shareholders meeting
Cassiopea SpA, a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products, today announced the results of the shareholders meeting held on March 18, 2019 in Lainate.